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Introduction

Conclusion

The Group A Streptococcus
(GAS) bacteria:
A large group of gram-positive, nonmotile, non-spore-forming cocci.
•
120 different strains , most common
bacterial pathogen. Easily treated
with antibiotics, but widespread.
•
Responsible for more than 700
million infections around the globe
each year (Ermet et al., 2015).
•
Untreated, can spread, become
systemic, organ damage.
•
Major health concern
•
GAS ranks among the top 10
infectious disease killers worldwide”
(Walker et al., 2014, p. 286).
The spectrum of diseases caused by GAS
infections is divided into two categories:
suppurative and non-suppurative.
Suppurative
Pharyngitis
Impetigo
Pneumonia
Empyema
Erysipelas
Necrotizing fasciitis
Cellulitis
Streptococcal bacteremia
Osteomyelitis
Otitis media
Sinusitis
Meningitis or brain abscess.
Non-suppurative
Acute rheumatic fever
Rheumatic heart disease
Acute glomerulonephritis
Scarlet fever
Endocarditis
Myocarditis
Pericarditis
Phlebitis
Streptococcal Toxic Shock
PANDAS
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Disease burden:

•

•
•

•

•
•
•
•

•
•

Globally, 500,000 deaths annually
In U.S. GAS revealed a cost of $500
million annually” (Steer et al., 2016).
9th leading infectious cause of
human mortality globally
18.1 million cases of severe disease,
616 million cases of pharyngitis,
GAS pharyngitis cost of at least $500
million annually in US, alone. (Steer
et al., 2016).
Lethality 10-30%
Annual death toll 500,000-650,000
(Terao, 2012).

The virulence factors and etiology of this
bacteria make it a powerful pathogen
that is capable of creating a large disease
burden that can affect a family and a
nation. Research is revealing genetic
factors that increase and decrease
susceptibility to a GAS infection. As this
research continues , the quest to develop
a GAS vaccine looks promising, but
poses many challenges. These factors
create several reasons why this powerful
pathogen is n note-worthy topic, and one
practitioners need to keep in mind.

The most common forms,
respiratory & skin infections,
Highly virulent
Overcoming host defense
Effective/invasive in epithelial cells
(Khan, 2016).
Cell wall complex, chemically
diverse.
Outermost capsule hyaluronic acid
Structure resembles host
Escapes recognition
Extracellular components: invasins
and exotoxins,
Host cell damage, inflammatory
response (Khan, 2016).
The antigenic components,
virulence factors:
Capsular polysaccharide (Csubstance) (Khan, 2016).
Peptidoglycan, lipoteichoic acid
(LTA) (Khan, 2016).
R and T proteins,
Various surface proteins I,M protein
(Khan, 2016).
Cell streptokinase (Khan, 2016)
C5A peptidase
Bacterial Adhesion Factors (Khan,
2016).
Streptolysin S-damages (Khan,
2016)
Streptolysin O (Khan, 2106)
Streptococcal pyrogenic exotoxins
(SPEs) A,
Liquefaction of pus, generates
substrate for growth (Khan, 2016).
inhibition of complement system
(Stevens & Bryant, 2015).
Opacity Factors (Khan, 2016).

Etiology:
•

•
•
•
•
•

•
•
•

•

•

Highly communicable
through person-to-person
transmission
respiratory droplets
salivary droplets
nasal discharge
skin to skin spread known to
occur with specific strains
fingernails and perianal
region can harbor
streptococci causing
impetigo
food and waterborne
outbreaks have been
documented (Khan, 2016).
Causes disease in healthy
people of all ages
Deficiency in specific type of
immunity against serotype
responsible for infection
(Khan, 2016).
Impetigo and pharyngitis
more likely to occur among
children living in crowded
homes or suboptimal
hygienic conditions (Khan,
2016).
Bacteria can live on dry
surfaces outside the body
for 3 days to 6.5 months
(Whiteman, 2013).

.

Pathophysiology and Significance of
Pathophysiology
S pyogenes colonization, usually in upper respiratory tract, and is
highly virulent as it overcomes the host defense system.
Cell wall complex and chemically divers.
Antigenic components of cell are the virulence factors.
Extracellular components responsible for disease process
include invasins and exotoxins.
Hyaluronic acid outermost capsule escapes recognition by
host.
Bacterium escapes phagocytosis by neutrophils or
macrophages, allowing colonization.
Epithelial cell invasion
Complement system activated
Classical pathway initiated by biding of antibodies to microbial
surface
Lectin pathway activated by binding one or more lectins to specific
carbohydrate structures
Alternative pathway triggered by ‘tickover’ mechanism followed by
amplification through positive feedback loop
All three pathways converge at the level of C3 deposition
Formation of C3 convertases generates chemoattractant
anaphylatoxins and further amplifies deposition of C3 fragments on
microbes, which opsonizes the microbial target for efficient
phagocytosis.
Gram-positive bacteria such as GAS are resistant to MAC-mediated
lysis, but are eliminated by phagocytes following opsonization with
C3b and iC3b.
The complement cascade is tightly regulated by surface bound and
soluble inhibitors (or regulators); C4b-binding protein (C4BP) and
Factor H (FH) are two examples of the latter which serve to prevent
damage to host tissues (Ermert et al., 2015).
“GAS has evolved several virulence factors, which allow the pathogen
to colonize its human host, escape the immune system and
successfully establish infection” (Ermert et al. 2015, p. 2)
Fibrinogen binding to GAS reduces opsonization.
IgG Fc binding to GAS may prevent recognition by phagocyte Fc
receptors.
M protein family members share high sequence identity. Certain M
or M-like proteins mediate GAS binding to human C4BP and FH
through Protein H, which is a member of M protein family.
Inhibition of complement activation through surface bound human
FH and C4BP enables GAS infections to evade opsonization. (Ermert
et al., 2015)
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Disease/Signs & Symptoms/
Nursing Care (select, please see paper for full list)
PharyngitisSigns and symptoms include sore throat, fever, swollen lymph nodes, chills, malaise,
nausea, and vomiting, red and white patches in the throat. Self-limiting, most signs and
symptoms subside after 3 to 4 days, but antibiotic treatment should be started within 9
days after onset of pharyngitis to prevent acute rheumatic fever (ARF) development.
Nursing Care- Prepare and administer prescribed antibiotics, analgesics. Educate
patient/family on the proper use of antibiotics to prevent misuse. Encourage warm saline
gargles, and use of throat lozenges, if recommended. Instruct the patient/family on
proper mouth care and use of new toothbrush 24 hours after beginning antibiotics.
Educate patient and family on the benefit of a bland, soft food diet until pain subsides.
Advise patient/family on increased fluid intake to 2,000 mL/per day where appropriate. If
patient cannot swallow, fluids may be administered by I.V. as ordered. Encourage client
to wear a disposable mask when exposed to environmental and occupational pollutants.
Assess and test family for intra-family spread of bacterial infection (Clores, 2015).
Impetigo/PyodermaSigns and symptoms include areas of acne or rash, small patches of inflamed skin, skin
infections, oozing vesicles, honey colored crust and scales, hair loss, scratching, licking,
and biting areas of infection, and depression.
Nursing Care- Teach proper washing and care of vesicles. Educate patient/family on
proper use of antibiotics, both oral and topical. Educate on infection control and
contagiousness of disease. Contact precautions should be initiated. Patient linens should
be washed,kept separate from other family members. Teach good handwashing.
Encourage patient to avoid irritants and pollution so additional bacteria and pathogens
can be avoided until infection subsides. Keep fingernails
cut short (Antipuesto, 2011).
.

Invasive GAS infection-

Sign and symptoms include fever, severe pain, swelling, and redness at wound site. More
systemic signs such as chills, myalgia, nausea, vomiting, and diarrhea may develop as
disease/infection progresses. Changes in blood pressure may occur as disease
progresses.
Nursing Care-Start and maintain I.V. line if indicated. Monitor temperature. Administer
antibiotics as prescribed. Educate patient/family on proper use of antibiotics. Wound
care, educating patient/family on appropriate wound care and infection prevention.
Prepare and educate patient and family on debridement procedures where indicated.
Encourage appropriate fluid intake and good nutrition. Assess and monitor patient for
signs of sepsis. Prepare I.V. immunoglobin G therapy if indicated for GAS TSS (Khan,
2016).

Glomerulonephritis
Signs and symptoms include blood, excess protein in urine, bubbly, foamy urine from
presence of protein, high blood pressure, peripheral, facial edema, frequent night time
urination, abdominal pain, and frequent nosebleeds.
Nursing Care- Provide best rest during acute phase. Monitor and regularly assess the
patient’s vital signs. Monitor lab values. Allow and assist with gradual return to normal
activities as symptoms subside. Perform or teach passive range of motion exercises while
on bed rest. Consult dietician about a diet high in calories, low in protein, sodium,
potassium, and fluids. Educate on good hygiene, infection prevention Monitor daily
weight, I and O. Assess for and report any sign of peripheral edema or formation of
ascites. Explain orthostatic hypotension if patient is on diuretics, and the dizziness when
quickly changing positions. Provide emotional support to the patient and family. If
dialysis is ordered, fully explain the process to patient and family (Nursing File, 2010).

GAS is an important pathogen
responsible for 700+ million infections
worldwide annually. The global burden
of invasive strep is I,663,000 new cases,
163,000 deaths each year (Ermert et al,
2015). Quick identification & treatment
of GAS iis paramount to control, arrest
the disease process, and prevent further
complications. It is important to prevent
spread, as GAS can spread easily
between humans with close contact;
droplet spread. Antibiotic therapy
treats most GAS infections if caught &
identified quickly. The effective
practitioner needs to be aware of the
prevalence of GAS infections and assess
patients, as is appropriate. No age group
or people group is completely immune to
GAS. Further research on a GAS vaccine
would prove valuable, and once
developed, the vaccine may help relieve
some of the worldwide disease burden
of this powerful pathogen.
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